journal article·2026-01-13

Ion-Pairing Therapeutic Agents to Overcome Immune Resistance for Enhancing Type I Near-Infrared Photodynamic Immuno/Chemotherapy

Haoran Hou, Hanhan Lu, Tai Sun, Siwen Wei, Yutong Shao, Gaobo Hong, Yanliang Zhao, Jianjun Du, Yingnan Wu, Fengling Song, Xiaojun Peng

ACS Nano· Volume 20· Issue 1
Publisher page

Abstract

Photodynamic therapy (PDT) is well-known to induce tumor immunotherapy by immunogenic cell death (ICD). However, oxygen-dependent Type II PDT paradoxically exacerbates hypoxia, driving PD-L1-mediated immune evasion and undermining therapeutic efficacy. Herein, we present an ion-pairing therapeutic agent (IPTA) strategy based on a Type I near-infrared (NIR) anionic photosensitizer and a mitochondrial-targeting cationic inhibitor. The designed ion-pairing therapeutic agent CyR-TL exhibits a dramatically enhanced singlet oxygen quantum yield (∼21.08-fold that of ICG) and excellent superoxide anion (O 2 –• ) generation capability, enabling effective tumor cell suppression under low-power and short-duration NIR irradiation across both normoxic and hypoxic conditions. Meanwhile, CyR-TL plays a role in chemotherapy-mediated suppression of mitochondrial oxidative phosphorylation to downregulate PD-L1, effectively counteracting PDT-induced immune resistance without requiring exogenous checkpoint inhibitors. Synergizing with PDT-triggered immunogenic cell death (ICD), the designed ion-pairing therapeutic agent integrates the hypoxia-tolerable NIR Type I PDT mechanism with PD-L1-downregulating capability for enhancing photodynamic immunotherapy and chemotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering

Dalian University of Technology

Department of Neurosurgery, Beijing Tiantan Hospital

Capital Medical University

Institute of Molecular Sciences and Engineering, Institute of Frontier and Interdisciplinary Science

Shandong University

College of Materials Science and Engineering

Shenzhen University

Funding

Science and Technology Foundation of Shenzhen City · Basic and Applied Basic Research Foundation of Guangdong Province · China Postdoctoral Science Foundation · National Natural Science Foundation of China · Natural Science Foundation of Shandong Province

References (65)

Show source-provided references
1. 10.1039/C7CS00594F10.1039/C7CS00594F ↗
2. 10.1038/s41570-024-00662-710.1038/s41570-024-00662-7 ↗
3. 10.1021/jacs.4c1324110.1021/jacs.4c13241 ↗
4. 10.1002/anie.20230016210.1002/anie.202300162 ↗
5. 10.1002/anie.20180513810.1002/anie.201805138 ↗
6. 10.1186/s40001-024-01780-010.1186/s40001-024-01780-0 ↗
7. 10.7150/thno.8009110.7150/thno.80091 ↗
8. 10.1186/s13045-021-01102-510.1186/s13045-021-01102-5 ↗
9. 10.1002/smll.20231150710.1002/smll.202311507 ↗
10. 10.1016/j.ymthe.2021.05.01710.1016/j.ymthe.2021.05.017 ↗
11. 10.1038/s41392-018-0022-910.1038/s41392-018-0022-9 ↗
12. 10.1111/php.1330010.1111/php.13300 ↗
13. 10.1021/jacs.6b0953810.1021/jacs.6b09538 ↗
14. 10.1186/s40425-018-0442-710.1186/s40425-018-0442-7 ↗
15. 10.1186/s13045-019-0817-310.1186/s13045-019-0817-3 ↗
16. 10.7150/thno.3842510.7150/thno.38425 ↗
17. 10.1186/s12943-024-02212-710.1186/s12943-024-02212-7 ↗
18. 10.1038/s41590-024-02015-410.1038/s41590-024-02015-4 ↗
19. 10.1038/s41571-019-0218-010.1038/s41571-019-0218-0 ↗
20. 10.1200/JCO.2017.77.638510.1200/JCO.2017.77.6385 ↗
21. 10.1002/adma.20220612110.1002/adma.202206121 ↗
22. 10.1021/acsnano.3c1011710.1021/acsnano.3c10117 ↗
23. 10.1038/cr.2017.15510.1038/cr.2017.155 ↗
24. 10.1038/nrm.2017.9510.1038/nrm.2017.95 ↗
25. 10.1038/s41580-022-00547-x10.1038/s41580-022-00547-x ↗
26. 10.1038/nrm331110.1038/nrm3311 ↗
27. 10.1016/j.molcel.2021.03.03710.1016/j.molcel.2021.03.037 ↗
28. 10.1038/s41419-020-03140-210.1038/s41419-020-03140-2 ↗
29. 10.1038/sj.onc.120262510.1038/sj.onc.1202625 ↗
30. 10.1038/s41467-019-10042-110.1038/s41467-019-10042-1 ↗
31. 10.1002/advs.20220760810.1002/advs.202207608 ↗
32. 10.1021/ar50015a00410.1021/ar50015a004 ↗
33. 10.1002/anie.20120544910.1002/anie.201205449 ↗
34. 10.1002/anie.20120534310.1002/anie.201205343 ↗
35. 10.1021/jacs.3c1269410.1021/jacs.3c12694 ↗
36. 10.1021/jacs.5c0223510.1021/jacs.5c02235 ↗
37. Anslyn E. V. · 2006
38. 10.1126/science.ade819010.1126/science.ade8190 ↗
39. 10.1038/nchem.131110.1038/nchem.1311 ↗
40. 10.1021/jacs.5b0807210.1021/jacs.5b08072 ↗
41. 10.1002/anie.20220309310.1002/anie.202203093 ↗
42. 10.1021/acs.jpcc.6b0303710.1021/acs.jpcc.6b03037 ↗
43. 10.1038/s41467-024-55429-x10.1038/s41467-024-55429-x ↗
44. 10.1021/ja043413z10.1021/ja043413z ↗
45. 10.1021/jp036250u10.1021/jp036250u ↗
46. 10.1021/jacs.1c0627510.1021/jacs.1c06275 ↗
47. 10.1039/C8CC04582H10.1039/C8CC04582H ↗
48. 10.1021/jacs.2c0325610.1021/jacs.2c03256 ↗
49. 10.1002/adma.20240218210.1002/adma.202402182 ↗
50. 10.1039/D4OB00520A10.1039/D4OB00520A ↗
51. 10.1021/jacs.7b0206310.1021/jacs.7b02063 ↗
52. 10.1021/jacs.2c0325610.1021/jacs.2c03256 ↗
53. 10.1038/s41467-021-21454-310.1038/s41467-021-21454-3 ↗
54. 10.1021/jacs.3c0104210.1021/jacs.3c01042 ↗
55. 10.1007/s12039-021-01925-210.1007/s12039-021-01925-2 ↗
56. 10.1002/adma.20210178410.1002/adma.202101784 ↗
57. 10.3390/molecules2917399510.3390/molecules29173995 ↗
58. 10.1039/D1SC01171E10.1039/D1SC01171E ↗
59. 10.2217/nnm.13.11810.2217/nnm.13.118 ↗
60. 10.1016/j.jddst.2023.10485410.1016/j.jddst.2023.104854 ↗
61. 10.1038/s41598-025-94291-910.1038/s41598-025-94291-9 ↗
62. 10.1038/s41467-021-25452-310.1038/s41467-021-25452-3 ↗
63. 10.1002/anie.20240876910.1002/anie.202408769 ↗
64. 10.1002/adma.20231346010.1002/adma.202313460 ↗
65. 10.1002/adma.20230971110.1002/adma.202309711 ↗